What We Have Gained from Ibogaine: α3β4 Nicotinic Acetylcholine Receptor Inhibitors as Treatments for Substance Use Disorders.
第一作者:
Carolyn J,Straub
第一单位:
Department of Pharmaceutical Sciences, College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois 60612, United States.
作者:
主题词
人类(Humans);伊波加因(Ibogaine);受体, 烟碱(Receptors, Nicotinic);物质相关性障碍(Substance-Related Disorders);剂量效应关系, 药物(Dose-Response Relationship, Drug)
DOI
10.1021/acs.jmedchem.2c01562
PMID
36440853
发布时间
2024-09-14
- 浏览0

Journal of medicinal chemistry
107-121页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文